Creo Medical Group PLC
LSE:CREO
Creo Medical Group PLC
LSE:CREO
Price:
35.875 GBX
-0.35%
Market Closed
Updated:
Apr 30, 2024
Section:
Relative Value
The Relative Value of one
CREO
stock under the Base Case scenario is
43.003
GBX.
Compared to the current market price of 35.875 GBX,
Creo Medical Group PLC
is
Undervalued by 17%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
CREO
Relative Value
Base Case
43.003
GBX
Undervaluation 17%
Valuation Multiples
Multiples Across Competitors
CREO Competitors Multiples
Creo Medical Group PLC Competitors
Creo Medical Group PLC Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| UK |
|
Creo Medical Group PLC
LSE:CREO
|
125.9m GBP | 4.3 | -5 | -4.2 | -3.7 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
184.4B USD | 4.6 | 32.7 | 19.3 | 28.7 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
131.7B USD | 18 | 66.3 | 54.3 | 68.1 | |
| US |
|
Stryker Corp
NYSE:SYK
|
128.4B USD | 6.3 | 40.6 | 25.3 | 31.3 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
107.2B USD | 3.3 | 25.5 | 13.6 | 19.2 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
105.3B USD | 7.4 | 67.1 | 31.2 | 46.6 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
67.7B USD | 3.5 | 55.5 | 18.6 | 39.3 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
57.8B EUR | 2.7 | 38.1 | 18.3 | 30.9 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
51.1B USD | 8.5 | 36.4 | 26.3 | 28.5 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
368.4B CNY | 10.7 | 32.5 | 28.3 | 28.3 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
49.5B USD | 13.7 | 91.5 | 61.6 | 80.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
